Neurol. praxi. 2009;10(4):228-236

Epilepsy pharmacotherapy according to clinical gidelines?

doc. MUDr. Jiří Hovorka CSc1,2
1 Neurologické oddělení, neuropsychiatrické a epileptologické centrum, Nemocnice Na Františku s poliklinikou, Praha
2 Neurochirurgická klinika 1. LF UK, Praha

Basic data of epilepsy treatment according to guidelines, expert consensus guidelines and expert opinions are presented.

Keywords: epilepsy, antiepileptic drugs, pharmacological treatment, guidelines.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hovorka J. Epilepsy pharmacotherapy according to clinical gidelines? Neurol. praxi. 2009;10(4):228-236.
Download citation

References

  1. Brázdil M. Moderní racionální terapie epilepsie. Neurol. pro praxi 2009; 10: 94-100.
  2. Brodie MJ, Peruna E, Ryvlin P, Ben-Menachem E, Meencke HJ. Comparison of levetiracetam and controlled-release carbamazepin in newly diagnose epilepsy. Neurology 2007; 68: 402-408. Go to original source... Go to PubMed...
  3. Dolanský J. Současná epileptologie. Triton, Praha, 2000: 1-165.
  4. EpiStop. Soubor minimálních diagnostických a terapeutických standardů u pacientů s epilepsií. EpiStop, Maxdorf, Praha 2007: 1-58. (www.epistop.cz)
  5. French JA, Kanner AM, Bautista J, Bergen D, Hirtz D, Montouris GD, Nespec M, Gidal B, Marks WJ, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faugh RE, Sachdeo RC, Beydoun A, Glauber TA. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1252-1260. (www.aan.com/professionals/index/cfm) Go to original source... Go to PubMed...
  6. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1261-1273. Go to original source... Go to PubMed...
  7. Glauser T, Ben-Menachem E, Bourgeois E, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perruca E, Tomson T. ILAE Treatment Guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 1094-1120. Go to original source... Go to PubMed...
  8. Hovorka J, Nežádal T. Kombinovaná léčba antiepileptiky u epilepsie: taktika, volba léků, interakce. Neurol. pro praxi, 2007; 2: 80-85.
  9. Karceski S, Morrell M, Carpenter D. The Expert Consensus Guideline Series: Treatment of Epilepsy. Epilepsy Behav 2001; 2: A1-A50. Go to original source...
  10. Komárek V. Léčba věkově vázaných epileptických syndromů s příznivější prognózou. Neurol. pro praxi, 2007; 2: 87-90.
  11. National Institute for Clinical Excellence (NICE). The Epilepsies. The diagnosis and management of the epilepsies in adults and children in primary and secondary care. Clinical Guideline 20. London 2004: 1-73. (www.nice.org.uk)
  12. Rektor I. Farmakoterapie epilepsie: limity a úskalí. Neurol. pro praxi, 2007; 2: 80-85.
  13. Rektor I. O padáku. In: Rektor I. Neuroeseje, Triton, Praha: 68-69.
  14. Rektor I. O standardech. In: Rektor I. Neuroeseje, Triton, Praha: 70-74.
  15. Rektor I, Kuba R. Nová antiepileptika u dospělých - nové informace. Neurol. pro praxi, 2007; 2: 70-74.
  16. Scotish Intercollegiate Guidelines Network (SIGN).Diagnosis and Management of Epilepsy in Adults. Edinburg 2003: 1-49. (www.sign.ac.uk)
  17. Shorvon S. We live in the age of the clinical guidelines. Editorial commentary. Epilepsia 2006; 47: 1091-1093. Go to original source...
  18. Sýkora V. Liečba epileptických syndrómov v detskom veku s nepriaznivou prognózou. Neurol. pro praxi, 2007; 2: 91-93.
  19. Zárubová J. Novinky ve farmakoterapii epilepsie. Farmakoterapie 2008; 1: 13-18.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.